Skip to main content
Clinical Trials/NCT04293328
NCT04293328UnknownNot Applicable

Accrued Effect of Orthokeratology for Myopia Control in Children and the Effectiveness of Myopia Control Using an Innovative Orthokeratology Modality. Experiment 2. Effect in New Ortho-k Wearers

The Hong Kong Polytechnic University1 site in 1 country30 target enrollmentStarted: July 7, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1
Primary Endpoint
Changes in Back Surface Lens Deposits

Study Overview

Brief Summary

The two-year prospective study aims at investigating frequently replacement effect on myopia control in young children, and the use of weekly protein removal system in monthly replacement modality orthokeratology lenses on surface deposit.

Detailed Description

In this two-year prospective study, low myopic children, aged 6-8 years, who have no prior experience in contact lens wear and myopia control treatment will be recruited. They will be prescribed with monthly replacement orthokeratology lenses for a period of one year. Axial elongation and ocular conditions during the study will be determined. Subjects will be randomly assigned to normal cleaning and intensive cleaning groups. Subjects in normal cleaning group will be provided with complimentary contact lenses solutions for daily cleaning and disinfection. In addition to the daily procedures for lens case, subjects in the intensive cleaning group will be required to perform weekly protein removal.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Independent examiners will be responsible for the assessment of the primary outcomes, which are the axial length and surface coating.

Eligibility Criteria

Ages
6 Years to 10 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Aged 6-10 years
  • •Normal ocular and general condition and not on medication which may contraindicate ortho-k lens wear
  • •Refractive sphere between -0.75 to -4.00 D, refractive cylinder ≤ -1.50 D and anisometropia ≤ -1.00 D
  • •Best correctable vision better than 0.08 logMAR in the worse eye
  • •Normal binocular function and accommodative status
  • •No prior experience in contact lens wear and myopia control treatment

Exclusion Criteria

  • •Strabismus at distance or near
  • •Contraindication for ortho-k lens wear
  • •Prior history of ocular surgery, trauma, or chronic ocular disease
  • •Systemic or ocular conditions that may interfere refractive development
  • •Systemic or ocular conditions that may interfere tear quality and contact lens wear
  • •Poor response to the use of study lenses
  • •Poor compliance to test procedures
  • •Poor compliance to the use of ortho-k lenses (e.g. use of solution, use of lenses)
  • •Poor compliance to follow-up schedule

Arms & Interventions

Monthly replacement lenses without protein removal

Experimental

Subjects will be required to perform daily cleaning for the monthly replacement orthokeratology lenses

Intervention: orthokeratology (Device)

Monthly replacement lenses with weekly protein removal

Active Comparator

Subjects will be required to perform both daily cleaning and weekly protein removal for the monthly replacement orthokeratology lenses

Intervention: orthokeratology (Device)

Monthly replacement lenses with weekly protein removal

Active Comparator

Subjects will be required to perform both daily cleaning and weekly protein removal for the monthly replacement orthokeratology lenses

Intervention: Menicon Progent A+B (Device)

Outcomes

Primary Outcomes

Changes in Back Surface Lens Deposits

Time Frame: Every month up to 24 months

Surface deposits will be graded using a 4-point scale: 0=no deposit; 1=mild; 2=moderate; 3=severe

Axial elongation in 2 years

Time Frame: 12 months

Elongation of the eyeball in 24 months

Secondary Outcomes

  • Number of participants with serious adverse effects in 2 years(24 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pauline Cho

Professor

The Hong Kong Polytechnic University

Study Sites (1)

Loading locations...

Similar Trials